(Q39259281)

English

Efficacy of ramosetron in the treatment of male patients with irritable bowel syndrome with diarrhea: a multicenter, randomized clinical trial, compared with mebeverine.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21920001%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Efficacy of ramosetron in the treatment of male patients with irritable bowel syndrome with diarrhea: a multicenter, randomized clinical trial, compared with mebeverine (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21920001%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

multicenter clinical trial

0 references

0 references

0 references

irritable bowel syndrome

1 reference

based on heuristic

inferred from title

Seung-Jae Myung

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21920001%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21920001%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21920001%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Poong-Lyul Rhee

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21920001%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

author name string

K J Lee

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21920001%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

N Y Kim

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21920001%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

J K Kwon

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21920001%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

K C Huh

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21920001%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

O Y Lee

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21920001%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

J S Lee

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21920001%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

S C Choi

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21920001%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

C I Sohn

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21920001%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

M K Choi

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21920001%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

language of work or name

1 reference

based on heuristic

inferred from title

publication date

15 September 2011

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21920001%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Neurogastroenterology and Motility

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21920001%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

23

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21920001%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21920001%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

1098-1104

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21920001%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Recognizing and managing patients with irritable bowel syndrome

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2011.01771.X

21 January 2018

The prevalence, symptom characteristics, and impact of irritable bowel syndrome in an asian urban community

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2011.01771.X

21 January 2018

Efficacy and safety of alosetron in women with irritable bowel syndrome: a randomised, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2011.01771.X

21 January 2018

Efficacy of alosetron in irritable bowel syndrome: a meta-analysis of randomized controlled trials

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2011.01771.X

21 January 2018

A randomized controlled clinical trial of the serotonin type 3 receptor antagonist alosetron in women with diarrhea-predominant irritable bowel syndrome

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2011.01771.X

21 January 2018

Inhibitory effects of ramosetron, a potent and selective 5-HT3-receptor antagonist, on conditioned fear stress-induced abnormal defecation and normal defecation in rats: comparative studies with antidiarrheal and spasmolytic agents

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2011.01771.X

21 January 2018

Effects of serotonin 5-HT3 receptor antagonists on stress-induced colonic hyperalgesia and diarrhoea in rats: a comparative study with opioid receptor agonists, a muscarinic receptor antagonist and a synthetic polymer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2011.01771.X

21 January 2018

A phase II trial of the novel serotonin type 3 receptor antagonist ramosetron in Japanese male and female patients with diarrhea-predominant irritable bowel syndrome

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2011.01771.X

21 January 2018

A randomized, double-blind, placebo-controlled clinical trial of the effectiveness of the novel serotonin type 3 receptor antagonist ramosetron in both male and female Japanese patients with diarrhea-predominant irritable bowel syndrome

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2011.01771.X

21 January 2018

Alosetron relieves pain and improves bowel function compared with mebeverine in female nonconstipated irritable bowel syndrome patients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2011.01771.X

21 January 2018

A systematic review of efficacy and tolerability of mebeverine in irritable bowel syndrome

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2011.01771.X

21 January 2018

Functional bowel disorders

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2011.01771.X

21 January 2018

Ramosetron, a 5-HT3 receptor antagonist for the control of nausea and vomiting

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2011.01771.X

21 January 2018

Selective serotonin 5-HT3 receptor antagonists for postoperative nausea and vomiting: are they all the same?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2011.01771.X

21 January 2018

Effects of 5-hydroxytryptamine (serotonin) type 3 antagonists on symptom relief and constipation in nonconstipated irritable bowel syndrome: a systematic review and meta-analysis of randomized controlled trials

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2011.01771.X

21 January 2018

Efficacy and tolerability of alosetron for the treatment of irritable bowel syndrome in women and men: a meta-analysis of eight randomized, placebo-controlled, 12-week trials

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2011.01771.X

21 January 2018

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39259281&oldid=1632604386"